Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency
Anirban Das, Sumedha Sudhaman, Daniel A. Morgenstern, et al.
Nature Medicine (2022) Vol. 28, Iss. 1, pp. 125-135
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment
Víctor A. Arrieta, Crismita Dmello, Daniel J. McGrail, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 2
Open Access | Times Cited: 123
Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology
Dominik Sturm, David Capper, Felipe Andreiuolo, et al.
Nature Medicine (2023) Vol. 29, Iss. 4, pp. 917-926
Open Access | Times Cited: 77
Immune escape and resistance to immunotherapy in mismatch repair deficient tumors
Guillaume Mestrallet, Matthew Brown, Cansu Cimen Bozkus, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 41
Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study
Ayse B. Ercan, Melyssa Aronson, Nicholas R. Fernandez, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 5, pp. 668-682
Closed Access | Times Cited: 25
Updates in IDH-Wildtype Glioblastoma
Jawad Melhem, Jay Detsky, Mary Jane Lim-Fat, et al.
Neurotherapeutics (2022) Vol. 19, Iss. 6, pp. 1705-1723
Open Access | Times Cited: 46
Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency
Anirban Das, Uri Tabori, Lauren C. Sambira Nahum, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 23, pp. 4770-4783
Open Access | Times Cited: 33
Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics—CheckMate 908
Ira J. Dunkel, François Doz, Nicholas K. Foreman, et al.
Neuro-Oncology (2023) Vol. 25, Iss. 8, pp. 1530-1545
Open Access | Times Cited: 28
Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer
Margherita Ambrosini, Benoı̂t Rousseau, Paolo Manca, et al.
Annals of Oncology (2024) Vol. 35, Iss. 7, pp. 643-655
Open Access | Times Cited: 9
Checkpoint Immunotherapy in Pediatrics: Here, Gone, and Back Again
Adrienne H. Long, Daniel A. Morgenstern, Amaury Leruste, et al.
American Society of Clinical Oncology Educational Book (2022), Iss. 42, pp. 781-794
Closed Access | Times Cited: 35
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti–PD-1 Monotherapy: A Report from the International RRD Consortium
Anirban Das, Nicholas R. Fernandez, Adrian Levine, et al.
Cancer Discovery (2023) Vol. 14, Iss. 2, pp. 258-273
Open Access | Times Cited: 21
Utility of molecular subtypes and genetic alterations for evaluating clinical outcomes in 1029 patients with endometrial cancer
Yuka Asami, Mayumi Kobayashi Kato, Kengo Hiranuma, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 8, pp. 1582-1591
Open Access | Times Cited: 20
Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies
Shizuko Sei, Aysel Ahadova, Derin B. Keskin, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 18
Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial
Theodore S. Johnson, Tobey J. MacDonald, Rafał Pacholczyk, et al.
Neuro-Oncology (2023) Vol. 26, Iss. 2, pp. 348-361
Open Access | Times Cited: 17
Immuno-oncologic profiling of pediatric brain tumors reveals major clinical significance of the tumor immune microenvironment
Adrian Levine, Liana Nobre, Anirban Das, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Genomic Microsatellite Signatures Identify Germline Mismatch Repair Deficiency and Risk of Cancer Onset
Jiil Chung, Logine Negm, Vanessa Bianchi, et al.
Journal of Clinical Oncology (2022) Vol. 41, Iss. 4, pp. 766-777
Open Access | Times Cited: 26
TMBserval: a statistical explainable learning model reveals weighted tumor mutation burden better categorizing therapeutic benefits
Yixuan Wang, Jiayin Wang, Wenfeng Fang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
“De novo replication repair deficient glioblastoma, IDH-wildtype” is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade
Sara Hadad, Rohit Gupta, Nancy Ann Oberheim Bush, et al.
Acta Neuropathologica (2023) Vol. 147, Iss. 1
Open Access | Times Cited: 14
DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology
Rifaquat Rahman, Diana D. Shi, Zachary J. Reitman, et al.
Neuro-Oncology (2024)
Open Access | Times Cited: 5
Precision immuno-oncology approach for four malignant tumors in siblings with constitutional mismatch repair deficiency syndrome
Hana Pálová, Anirban Das, Petra Pokorná, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 5
The Safety and Efficacy of Immune Checkpoint Blockade in Children, Adolescents, and Young Adults: A Systematic Review and Meta-Analysis
Pedro Cotta Abrahão Reis, João Evangelista Ponte Conrado, Mariana Macambira Noronha, et al.
EJC Paediatric Oncology (2025), pp. 100215-100215
Open Access
Frequency and Impact of Constitutional Mismatch Repair Deficiency in Patients With High-Grade Glioma, a Retrospective Analysis of 7 Years in Pakistan: an IRRDC Study
Naureen Mushtaq, Khurram Minhas, Farrah Bashir, et al.
JCO Global Oncology (2025), Iss. 11
Open Access
Cancer Predisposition Syndromes Associated with Most Common Pediatric Solid Tumors
Jennifer Scull, Dolores H. López Terrada
Surgical pathology clinics (2025)
Closed Access
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols
Tricia R. Cottrell, Michael T. Lotze, Alaa M. Ali, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010928-e010928
Open Access
Overt and covert genetic causes of pediatric acute lymphoblastic leukemia
Ulrik Kristoffer Stoltze, Stefanie V. Junk, Anna Byrjalsen, et al.
Leukemia (2025)
Closed Access
Coming in from the cold: overcoming the hostile immune microenvironment of medulloblastoma
Tanja Eisemann, Robert J. Wechsler‐Reya
Genes & Development (2022) Vol. 36, Iss. 9-10, pp. 514-532
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top